Carolyn R. Bertozzi
CIK: 0001698766
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 17, 2026OABI
OmniAb, Inc.
Exercise(M)Direct20K shares- - Jun 17, 2026OABI
OmniAb, Inc.
Award(A)DirectRestricted Stock Units
20K shares- - Jun 17, 2026OABI
OmniAb, Inc.
Award(A)DirectStock Option (right to buy)
40K shares- - Nov 1, 2025OABI
OmniAb, Inc.
Exercise(M)Direct17.8K shares- - Jun 17, 2025OABI
OmniAb, Inc.
Award(A)DirectRestricted Stock Units
20K shares- - Jun 17, 2025OABI
OmniAb, Inc.
Award(A)DirectStock Option (right to buy)
40K shares- - Jun 17, 2025OABI
OmniAb, Inc.
Exercise(M)Direct20K shares- - May 8, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
Award(A)Direct775 shares- - Nov 1, 2024OABI
OmniAb, Inc.
Exercise(M)Direct17.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  OABI OmniAb, Inc. | Exercise(M) | 20,000 | - | $0 | Direct |
| Jun 17, 2026 | OABI OmniAb, Inc. | Award(A) Restricted Stock Units | 20,000 | - | - | Direct |
| Jun 17, 2026 | OABI OmniAb, Inc. | Award(A) Stock Option (right to buy) | 40,000 | - | - | Direct |
| Nov 1, 2025 | OABI OmniAb, Inc. | Exercise(M) | 17,769 | - | - | Direct |
| Jun 17, 2025 | OABI OmniAb, Inc. | Award(A) Restricted Stock Units | 20,000 | - | - | Direct |
| Jun 17, 2025 | OABI OmniAb, Inc. | Award(A) Stock Option (right to buy) | 40,000 | - | - | Direct |
| Jun 17, 2025 | OABI OmniAb, Inc. | Exercise(M) | 20,000 | - | - | Direct |
| May 8, 2025 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Award(A) | 775 | - | - | Direct |
| Nov 1, 2024 | OABI OmniAb, Inc. | Exercise(M) | 17,769 | - | $0 | Direct |
1-9 of 9 transactions
About Bertozzi Carolyn R
Bertozzi Carolyn R (SEC CIK 0001698766) files insider reports with the SEC as 10% Owner of Lycia Therapeutics, Inc. (LYCA), Director of OmniAb, Inc. (OABI) and Director of ELI LILLY & Co (LLY). Signal8 also holds filings tied to 1 other company.
Signal8 holds 7 ownership filings by Bertozzi Carolyn R (2 Form 3, 5 Form 4), filed between Nov 1, 2024 and Oct 22, 2026. Those filings report 9 transactions, from Nov 1, 2024 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bertozzi Carolyn R's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Bertozzi Carolyn R
- Jun 17, 2026: Option exercise of OABI shares (Form 4, code M).
- Jun 17, 2026: Grants or awards of OABI derivative securities (2 lines, Form 4, code A).
- Nov 1, 2025: Option exercise of OABI shares (Form 4, code M).
- Jun 17, 2025: Grants or awards of OABI derivative securities (2 lines, Form 4, code A).
- Jun 17, 2025: Option exercise of OABI shares (Form 4, code M).
Other insiders filing for Lycia Therapeutics, Inc. (LYCA)
- Venrock Healthcare Capital Partners III, L.P., 10% Owner
- Versant Ventures VII GP, L.P., 10% Owner
- Fischer Laurent, Director
- Henderson Jane, Director
- RIEFLIN WILLIAM JL, Director
- Touami Sofia, Chief Business Officer